PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Computer model suggests genetic breast cancer screening may benefit those at intermediate risk

Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial

2013-12-05
(Press-News.org) Contact information: Kerry Sinclair
kerry.sinclair@gcihealth.com
310-710-0321
GCI Health
Computer model suggests genetic breast cancer screening may benefit those at intermediate risk Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial San Francisco, CA, USA – December 5, 2013 – Archimedes Inc., a healthcare modeling and analytics company, today announced results of a simulated clinical trial which found that the seven single-nucleotide polymorphisms (7SNP) genetic test for breast cancer was most cost effective when used to guide MRI screenings for patients found to have an intermediate lifetime risk of developing the disease. The study, "Cost-effectiveness of a genetic test for breast cancer risk," appeared in the December 5th online issue of the peer-reviewed journal Cancer Prevention Research.

"This Archimedes Model simulation suggests that genetic screening for breast cancer risk in conjunction with MRI can reduce cancer deaths and identifies a population at an intermediate risk near 20 percent for which it is optimally cost effective," said Tuan Dinh, PhD, vice president of analytics and modeling at Archimedes and one of the authors of study. "This study further illustrates that risk modeling may provide information that will enable physicians to better determine a patient's risk of disease and more appropriately allocate resources that will be beneficial."

In 2007, the American Cancer Society recommended MRI as an adjunct to mammography for the screening of breast cancer in women who have a lifetime risk of breast cancer of approximately 20-25 percent or greater as determined by models based on family history such as the Gail test. In the virtual study, researchers used Archimedes' detailed simulation model of breast cancer risk factors, disease progression, and healthcare processes to estimate the costs and benefits of using genetic testing to refine estimates of risk for purposes of referring women to MRI screening. The simulation included growth, detection, and spread of tumors, as well as screening and treatment.

The model compared two tests to categorize patients by lifetime risk, the Gail risk test and the 7SNP test. The Gail model, which is widely used by the National Cancer Institute, estimates risk using information on age, race, family history, and age of menarche and first live birth. The 7SNP genetic test uses the genotype of the patient to refine the estimate of the Gail test. In the simulated study, average-risk patients received an annual mammogram and high-risk patients received an annual MRI.

The simulated population consisted of 100,000 non-Hispanic white women starting at the age of 40 with no prior history of cancer and a lifetime Gail risk of breast cancer of at least 10 percent. Cancer incidence was based on Surveillance, Epidemiology, and End Results (SEER) data and validated to the Cancer Prevention Study II (CPS-II) Nutrition Cohort dataset. Risk factors were drawn from the National Health and Nutrition Examination Survey (NHANES-4) and Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial data. Mammogram characteristics were derived from Breast Cancer Surveillance Consortium data.

For patients with a lifetime risk of at least 10 percent, the model showed that the 7SNP test results in a 2.7 percent reduction in cancer deaths relative to the Gail test alone. For patients with a risk of 16-28 percent, the 7SNP test saved 0.005 quality-adjusted life years (QALY) per person at a cost of $163,264 per QALY. The cost effectiveness of using the 7SNP test for patients with intermediate Gail risk is similar to that of other recommended strategies, including annual MRI for patients with a lifetime risk greater than 20 percent or BRCA1/2 mutations, for which the model estimated a cost of $141,415 per QALY, relative to mammogram.

"These findings may help physicians and their patients as they strive to identify optimal breast cancer screening options for individual women based on their current risk profile," added Dr. Henri Folse, lead author of the study. "In addition, investigators can use mathematical modeling and cost-effectiveness analyses, such as those described in this study, to identify an optimal range of risk for which prevention and screening strategies are most cost effective."

This study was a collaborative project between Archimedes and Genetic Technologies Ltd.

INFORMATION:

ABOUT ARCHIMEDES

Archimedes, Inc. is a healthcare modeling and analytics organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions, and healthcare systems. Archimedes continually validates the Model by comparing the results of simulated trials to the results of multinational clinical trials and cohort studies. Through products such as IndiGO and ARCHeS, Archimedes helps people understand the implications of their decisions. For the last 15 years, Archimedes has assisted health plans, health systems, medical groups, patients, pharmaceutical companies, researchers, and other organizations in the United States and Europe answer questions related to health and economic outcomes research, policy creation, clinical trial design, and performance improvement. Archimedes, a Kaiser Permanente Innovation, is based in San Francisco, California. For more information about Archimedes and its product offerings, please visit the company's website at http://www.archimedesmodel.com

Media Contact:
Edie DeVine
GCI Health for Archimedes
edie.devine@gcihealth.com
415-365-8543

END



ELSE PRESS RELEASES FROM THIS DATE:

Social ties more important than biology when it comes to teen sleep problems

2013-12-05
Social ties more important than biology when it comes to teen sleep problems WASHINGTON, DC, December 2, 2013 — Medical researchers point to developmental factors, specifically the decline of the sleep-inducing hormone melatonin, as an explanation for ...

Blacks happier at work than whites despite fewer friends, less autonomy

2013-12-05
Blacks happier at work than whites despite fewer friends, less autonomy WASHINGTON, DC, December 2, 2013 — Despite working in more routine and less autonomous jobs, having fewer close friends at work, and feeling less supported by their coworkers, blacks ...

Pediatric infectious disease chief authors new vaccination guideline for immunocompromised patients

2013-12-05
Pediatric infectious disease chief authors new vaccination guideline for immunocompromised patients NEW HYDE PARK, NY – A new guideline released Thursday by the Infectious Diseases Society of America (IDSA) notes that most people with compromised ...

UCSB team discovers how to change cell types by flipping a single switch

2013-12-04
UCSB team discovers how to change cell types by flipping a single switch With few exceptions, cells don't change type once they have become specialized — a heart cell, for example, won't suddenly become a brain cell. However, new findings by researchers ...

Scripps leads first global snapshot of key coral reef fishes

2013-12-04
Scripps leads first global snapshot of key coral reef fishes Fishing has reduced vital seaweed eaters by more than 50 percent, report reveals In the first global assessment of its kind, a science team led by researchers at Scripps Institution of Oceanography ...

New insights into cancer evolution help define screening window of opportunity

2013-12-04
New insights into cancer evolution help define screening window of opportunity Genetic changes that occur as precancerous cells turn malignant could help researchers design new screening strategies SEATTLE – A new appreciation of how cancer cells evolve ...

Fruit pest targeted by genomic research

2013-12-04
Fruit pest targeted by genomic research The spotted wing drosophila, a major pest that targets berries and cherries and other fruits in the United States, Canada and Europe, is itself being targeted, thanks to groundbreaking genome sequencing at the University ...

Prostate cancer stem cells are a moving target, UCLA researchers say

2013-12-04
Prostate cancer stem cells are a moving target, UCLA researchers say UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies. Following ...

Radiographic imaging exposes relationship between obesity and cancer

2013-12-04
Radiographic imaging exposes relationship between obesity and cancer Even with healthy BMI, greater visceral fat may put older men at risk for cancer Researchers at the National Institute for Aging are working to improve understanding about ...

Intense 2-color double X-ray laser pulses: a powerful tool to study ultrafast processes

2013-12-04
Intense 2-color double X-ray laser pulses: a powerful tool to study ultrafast processes A team working at the SACLA X-ray Free-Electron Laser (XFEL) in Japan has succeeded in generating ultra-bright, two-color X-ray laser pulses, for the first time in the hard X-ray region. ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] Computer model suggests genetic breast cancer screening may benefit those at intermediate risk
Study findings published in Cancer Prevention Research underscore viability of simulation modeling to stratify patients by disease risk to better focus resources where most beneficial